Portopulmonary hypertension and hepatopulmonary syndrome: two different entities affecting pulmonary vasculature in liver disease.
Martinez-Pallí
Graciela
G
Vidal
Jaime Balust
JB
Beltrán
J
J
Taurà
Pilar
P
D000959:Antihypertensive Agents / Q000008:administration & dosage; D011464:Epoprostenol / Q000008:administration & dosage; D020065:Hepatopulmonary Syndrome / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D006801:Humans; D006975:Hypertension, Portal / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology*; D017093:Liver Failure / Q000401:mortality / Q000503:physiopathology*; D016031:Liver Transplantation / Q000502:physiology*; D011183:Postoperative Complications / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology; D011300:Preoperative Care; D015996:Survival Rate
D000959:Antihypertensive Agents; D011464:Epoprostenol